An Unbiased View of Ago tumor
Set up immune markers continue to maintain their relevance for clinical final decision-producing in breast most cancers treatment with even prolonged meanings. Estrogen receptor (ER) amount shouldn't only be classified in good or damaging. Reduced ER levels ≤ten% of labeled cells should be taken care of in a different way (LoE 1a/A/AGO++). Tumors